Fake Drugs Worth ₹ 27.91 Lakh Sent Back To Baddi From Agra, Seized

Solan : A consignment of spurious drugs having a face value of ₹ 27,91,445, manufactured by Baddi-based Trizal Formulation in the name of three renowned companies, was sent back to Baddi by a transport company from Agra following the directions of local drugs officials.

The drugs in 12 boxes had been couriered by kingpin of the spurious drug racket Mohit Bansal on November 21, a day before his arrest, to his wholesale firm MH Pharma in Agra. The officials today seized the consignment from the godown of the transport company TCI in Baddi, said State Drugs Controller Navneet Marwaha.

The Drugs Control Administration (DCA) had alerted the Uttar Pradesh DCA about this consignment on December 1. The consignment had remained undelivered as Bansal’s firm was sealed after the spurious drug racket was detected. The drugs were lying with the TCI in Agra.

“The recovered drugs comprise 1,77, 300 spurious tablets of different brands — Montair- 10, Roseday-10 and Glimisave-M2 tablets. The transport agency was directed to return the consignment as it purportedly contained spurious drugs. Two Drugs Inspectors escorted the transport vehicle from Agra to Baddi to avoid any tampering.”

Marwaha added that the arrest of the accused and timely action against the wholesale firm at Agra by the HP Drugs Control Department prevented the sale of spurious tablets.

The seized drugs comprise drugs used for common ailments. Roseday-10 is used to lower cholesterol, Glimisave-M2 is an anti-diabetic drug and Montair-10 is used by asthma patients. These carried the name of leading companies like Cipla, Eris and USV Private Limited.

Bansal was arrested with a cache of spurious drugs in his car on November 22 near the inter-state barrier at Baddi along with his two associates Atul Gupta and Vijay Kaushal.

  • Related Posts

    • Pharma
    • June 25, 2025
    • 101 views
    Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; Check price, dosage and other details

    A major face-off is expected in India’s growing anti-obesity treatment market, as Danish pharma giant Novo Nordisk rolled out its blockbuster weight-loss drug Wegovy on Tuesday, just a month after…

    • Pharma
    • June 25, 2025
    • 110 views
    Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg

    Hyderabad:  Aurobindo Pharma Ltd wholly owned step-down subsidiary CuraTeQ Biologics has obtained marketing authorization from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for Dyrupeg, its pegylated filgrastim biosimilar…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; Check price, dosage and other details

    Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; Check price, dosage and other details

    Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg

    Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg

    Sun Pharma’s European partner withdraws application for skin cancer treatment therapy

    Sun Pharma’s European partner withdraws application for skin cancer treatment therapy

    Glenmark Pharma launches TEVIMBRA in India

    Glenmark Pharma launches TEVIMBRA in India